Connect to other sites within the UBM Medica Network
Increased Diabetes Risk in Hodgkin Lymphoma Survivors
Hodgkin lymphoma survivors who were treated with infradiaphragmatic radiotherapy have an increased risk of developing diabetes mellitus, says a new study.
E-Cigarettes Fail to Help Cancer Patients Quit Smoking
A new study found that in cancer patients who smoke, e-cigarette users had greater nicotine dependence, compared to smokers of traditional cigarettes.
Predicting Therapy Resistance in AML Lacks Accuracy
A study of more than 4,500 patients with acute myeloid leukemia (AML) found that predicting resistance to therapy remains an elusive practice.
PD-L1 Positivity Confers Worse Outcomes in Non–Clear Cell RCC
In patients with non–clear cell RCC, PD-L1 positivity is associated with worse clinical outcomes, including a shorter overall survival and time to recurrence.
AR-V7 Linked to Targeted Therapy Resistance in Prostate Cancer
A new study found that the androgen receptor splice variant 7 is associated with resistance to two therapies for metastatic castration-resistant prostate cancer.
Maintenance Pazopanib in Ovarian Cancer: No Survival Benefit, High AEs
Maintenance therapy with pazopanib improved progression-free survival by 5.6 months in advanced ovarian cancer patients, according to results of a new study.
Baldness in Middle Age May Be Linked to Aggressive Prostate Cancer
A large trial found that men with moderate baldness at age 45 had an increased risk of developing aggressive prostate cancer compared with men with no baldness.
How Do You Say Goodbye?
Oncologists should be experts at farewells. I often write a note of condolence if I have not made personal contact with the patient or family close to the time of death.
CancerLinQ: ASCO Dives Into Big Data
In this interview we discuss the American Society of Clinical Oncology’s (ASCO) health information and patient record initiative called CancerLinQ.
Sensory Dysfunction Prevalent in Multiple Myeloma Patients
Multiple myeloma patients may already suffer from sensory deficits prior to treatment, likely due to disease-related decreases in peripheral innervation density.
By clicking Accept, you agree to become a member of the UBM Medica Community.